NCT05559437 is a Phase 1 clinical trial of Levo-bupivacaine 0.25 in Inguinal Hernia Repair, sponsored by Egymedicalpedia.

Who is sponsoring NCT05559437?

NCT05559437 is sponsored by Egymedicalpedia.

What drugs are being tested in NCT05559437?

Interventions in NCT05559437: Levo-bupivacaine 0.25.

What condition does NCT05559437 study?

NCT05559437 studies Inguinal Hernia Repair, Pain, Postoperative.

Is NCT05559437 still recruiting?

NCT05559437 is currently completed. Last updated 19 October 2023.

Last reviewed 2023-10-19 · How we verify

NCT05559437

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasound-guided Ilioinguinal/Iliohypogastric Nerve Block

Completed Phase 1 Last updated 19 October 2023

What this trial tests

Phase 1 trial testing Levo-bupivacaine 0.25 in Inguinal Hernia Repair in 60 participants. Completed in 20 April 2023.

Timeline

1 October 2022

Primary endpoint
1 April 2023

20 April 2023

Quick facts

Lead sponsor	Egymedicalpedia
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	60
Start date	1 October 2022
Primary completion	1 April 2023
Estimated completion	20 April 2023
Sites	1 location across Egypt

Drugs / interventions tested

Levo-bupivacaine 0.25 — full drug profile →

Conditions studied

Inguinal Hernia Repair — all drugs for Inguinal Hernia Repair →
Pain, Postoperative — all drugs for Pain, Postoperative →

Sponsor

Egymedicalpedia — full company profile →

Who can join

Adults 20 to 40, any sex, with Inguinal Hernia Repair or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Abdominal wall hernias are common, with a prevalence of 1.7% for all ages and 4% for those aged over 45 years. Inguinal hernias account for 75% of abdominal wall hernias, with a lifetime risk of 27% in men and 3% in women. Repair of inguinal hernia is one of the most common operations in general surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Inguinal Hernia Repair

Currently open trials in the same condition.

NCT07511764 — Comparison of Laryngeal Mask Airway Versus Endotracheal Intubation in Pediatric Laparoscopic Inguinal Hernia Repair: A M · NA · recruiting
NCT07252999 — Comparison of Outcomes of Hernia Sac Transection and Sac Reduction in Open Pediatric Inguinal Hernia Repair in Ramathibo · NA · recruiting

Other Egymedicalpedia trials

Trials by the same sponsor.

NCT06590818 — The Effect of Body Mass Index on Short-term Results of HTO · NA · recruiting
NCT06583811 — Remifentanil and Remimazolam to Limit Patient Movement · NA · recruiting
NCT06522984 — Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid · NA · recruiting
NCT06370078 — Effect of Early Administration of Albumin 20% Versus Crystalloid · NA · recruiting
NCT06370221 — The Effect of Psoriatic Arthritis on Female Sexual Dysfunction · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05559437 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Egymedicalpedia
Last refreshed: 19 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05559437.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing